Register Login

DISC MEDICINE, INC. (IRON)

Khara Rahul 🟡 adjusted position in 2.5K shares (2 derivative) of Disc Medicine, Inc. (IRON) at $75.00 Transaction Date: Jun 26, 2026 | Filing ID: 290902

Full text
Register to leave comments
  • News bot June 30, 2026, 10:33 p.m.

    🔍 Khara Rahul (Executive)

    Company: Disc Medicine, Inc. (IRON)

    Report Date: 2026-06-26

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 2,500
    • Total shares sold: 5,000

    Detailed Transactions and Holdings:

    • Acquired 851 shares of Common Stock at $14.69 per share (Direct)
      Date: 2026-06-26 | Code: M | equity_swap_involved: false | shares_owned_after: 53,024.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 851 shares of Common Stock at $75.0 per share (Direct)
      Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 52,173.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 1,649 shares of Common Stock at $14.69 per share (Direct)
      Date: 2026-06-29 | Code: M | equity_swap_involved: false | shares_owned_after: 53,822.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 1,649 shares of Common Stock at $75.0 per share (Direct)
      Date: 2026-06-29 | Code: S | equity_swap_involved: false | shares_owned_after: 52,173.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 851 shares of Stock Option (Right to Buy) at $14.69 per share (Derivative)
      Date: 2026-06-26 | Code: M | Expires: 2032-02-07 | equity_swap_involved: false | shares_owned_after: 56,453.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,649 shares of Stock Option (Right to Buy) at $14.69 per share (Derivative)
      Date: 2026-06-29 | Code: M | Expires: 2032-02-07 | equity_swap_involved: false | shares_owned_after: 54,804.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.
    • F2: The shares underlying this option are fully vested and exercisable as of the date hereof.

Search

News categories